ENOV Enovis CORP Insider Trading

CAO Oliver Engert bought 1,000 shares of ENOV at $20.92; stock now $21.58, down 41.4% from 52-week high of $36.82

Oliver Engert, Chief Administrative Officer, purchased 1,000 shares at $20.92 on 2026-06-15, increasing his holdings to 53.6K shares. The company is unprofitable (net income of -$8.8M in the latest quarter) despite posting annual revenue growth of +6.7%, creating a context of operational strain. Engert's cross-ticker track record shows 9 prior open-market buys averaging -5.2% return over 30 days and -6.9% over 90 days, with a 90-day win rate of 11.11%. At this specific ticker (ENOV), his 5 prior buys generated mixed results: only 1 of 5 prior purchases was well-timed at the 90-day mark, and the most recent buy on 2026-06-01 resulted in -5.0% over both the 30-day and 90-day periods. The current price of $21.58 reflects a 30-day decline of -11.2% and a 90-day decline of -5.9%, positioning the stock -41.4% from its 52-week high of $36.82.

CAO Oliver Engert buys 1,000 shares of ENOV at $23.00; stock down -42.6% from 52-week high, company unprofitable.

Oliver Engert, Chief Administrative Officer of Enovis, purchased 1,000 shares at $23.00 on 2026-06-10, increasing his holdings to 50,640 shares. The purchase occurs as the stock trades at $21.12, down -42.6% from its 52-week high of $36.82 and down -18.7% over the prior 30 days. Notably, Engert's five prior purchases at ENOV show a weak timing record: only 1 of 5 prior buys achieved positive 90-day returns (well-timed), while his cross-ticker track record across 9 prior buys averaged -6.9% 90-day returns with an 11.11% win rate. The company remains unprofitable with net income of $-8.8M on revenue of $589.2M in the latest quarter, which tempers any conviction signal from the open-market buy.

CAO Oliver Engert buys 1,000 ENOV shares at $22.22; stock now $21.56, down 41.4% from 52-week high.

Oliver Engert, Chief Administrative Officer of Enovis, purchased 1,000 shares at $22.22 on 2026-06-01, increasing his holdings from 48,640 to 49,640 shares. The stock has declined to $21.56 since purchase and sits 41.4% below its 52-week high, with negative momentum (-7.6% in 30 days, -11.4% in 90 days). His prior five buys at ENOV posted no positive 90-day returns, including recent purchases in March that underperformed over the longer horizon. The company remains unprofitable on a full-year basis (net income $-8.8M) despite 6.7% annual revenue growth, adding fundamental headwinds to near-term stock performance.

CAO Oliver Engert buys 1,000 ENOV shares at $23.74; stock down 42.0% from 52-week high amid unprofitability

Oliver Engert, Chief Administrative Officer, purchased 1,000 shares of Enovis at $23.74 on 2026-03-13, adding to his holdings of 48.6K shares post-transaction. This marks the fifth buy in a tight five-day window (2026-03-04 through 2026-03-13), suggesting sustained accumulation during a period of significant price weakness. The stock currently trades at $23.21, down 42.0% from its 52-week high of $40.00, though it has recovered 6.6% over the past 30 days. The company remains unprofitable with a net income of $-571.1M against quarterly revenue of $548.9M, which provides context for the depressed valuation. Without measurable outcomes from the five recent trades and given the company's ongoing losses, the pattern reflects opportunistic accumulation at reduced prices rather than a clear affirmation of near-term recovery.

CAO Oliver Engert buys 1,000 shares at $23.93; part of 5 consecutive buys in 7 days amid -41.5% drawdown from 52-week high

Engert purchased 1,000 shares of Enovis (ENOV) at $23.93 on 2026-03-10, following four consecutive open-market purchases over the preceding week (2026-03-03 through 2026-03-09). This acquisition brings his holdings to 47,640 shares. The pattern of repeated buying occurs while the stock is trading at -41.5% from its 52-week high of $40.00, and follows a 90-day decline of -11.6% despite a recent 30-day rebound of +3.6%. Notably, the company reported net income of $-571.1M in its most recent period with quarterly revenue of $548.9M, indicating material unprofitability; annual revenue growth stands at +6.7%, but the company operates at a substantial loss. The timing of these multiple purchases near depressed valuations against a backdrop of ongoing losses warrants examination of whether management has visibility into operational improvement or whether the buying reflects ordinary portfolio activity.

Chief Administrative Officer Engert Oliver bought 1,750 shares at blended average $23.83 on ENOV; stock down 40.3% from 52-week high.

Engert Oliver completed 3 separate purchases totaling 1,750 shares for $41,700.00 across March 6–9, 2026, at prices ranging from $23.39 to $24.48. The purchases increased his holdings by 3.9% to 46,640 shares post-transaction. The company is unprofitable (net income $-571.1M on revenue of $548.9M) and the stock trades at $23.89, down 40.3% from its 52-week high of $40.00, though it has recovered 5.8% over the prior 30 days. The insider's prior trades at ENOV are all recent and too recent to have measurable 90-day outcomes, limiting assessment of this insider's historical timing accuracy at this specific ticker.

CAO Oliver Engert bought 1,250 shares (1.2K) at blended $24.84 in 2 transactions; stock down -39.2% from 52-week high.

Engert, serving as Chief Administrative Officer, purchased 1,250 shares across two separate transactions on 2026-03-03 and 2026-03-04 at an average price of $24.84, increasing his holdings from 43,640 to 44,890 shares (a 2.9% increase). The transaction occurs against a backdrop of material company distress: Enovis posted a net loss of $-571.1M against revenue of $548.9M in its latest quarter, and the company was unprofitable over its most recent full fiscal year. The stock is currently trading at $24.32, reflecting a -39.2% decline from its 52-week high of $40.00, though it has recovered 11.6% over the past 30 days. Engert's prior open-market activity at this ticker is limited to a single buy on 2026-02-27 with outcomes not yet measurable; his cross-ticker track record shows only 1 prior buy overall. The modest transaction size relative to his existing holdings and the company's severe financial deterioration warrant monitoring to determine whether this represents confidence in operational recovery or routine portfolio activity during depressed pricing.

CAO Oliver Engert bought 1,000 shares of ENOV at $25.50; stock now $25.29, down -36.8% from 52-week high.

Oliver Engert, Chief Administrative Officer, purchased 1,000 shares (1.0K shares) at $25.50 on 2026-02-27, increasing his holdings to 43,640 shares (43.6K shares). The purchase occurred at a price only $0.21 above the current market price of $25.29, but the stock is trading -36.8% below its 52-week high of $40.00, suggesting a meaningful pullback from recent peaks. Enovis remains unprofitable with a full-year net income of $-571.1M despite revenue of $548.9M, and the insider's cross-ticker track record shows only 1 prior buy with no measurable outcomes at this ticker yet, limiting visibility into his historical buy accuracy. The modest share count increase of 2.3% relative to pre-transaction holdings and the limited historical pattern provide insufficient basis to infer strategic conviction or market timing significance.

PAO John Kleckner purchased 2,468 shares of ENOV at $30.32 ($74.8K); stock down 38.6% from 52-week high and trading below transaction price.

John Kleckner, serving as Principal Accounting Officer, purchased 2,468 shares at $30.32, bringing his holdings to 12,302 shares, a 25.1% increase in his position. The transaction occurs as Enovis trades at $30.27—near the purchase price—but well below the $49.33 52-week high, reflecting material deterioration in stock performance. The company reported a negative net income of $-571.1M in its most recent fiscal year despite quarterly revenue of $548.9M and annual growth of 23.5%, highlighting a significant profitability challenge. An insider acquisition by a senior finance officer during a period of substantial stock weakness and reported operating losses provides context for investor monitoring of both the company's path back to profitability and any governance signals this trade may convey.

CEO Damien McDonald bought 6,457 shares of ENOV at $30.97 for $199,973.29 as company remains unprofitable.

CEO Damien McDonald purchased 6,457 shares at $30.97 on 2025-09-11, increasing his holdings by 6.7% to 102,753 shares. The purchase occurred at a price that is 36.0% below the 52-week high of $49.33 and represents a modest 9.8% rebound from the 30-day low. However, the underlying business context is concerning: Enovis reported a loss of $36,739,000.00 in its latest quarter despite posting strong 23.5% annual revenue growth of $564,545,000.00, and the company remains unprofitable on a full-year basis. An insider equity purchase by a CEO is a data point, but its weight here is tempered by the company's negative net income trajectory and the absence of a clear path to profitability disclosed in the filings reviewed.